Company / Operating Income per Share
Day One Biopharmaceuticals, Inc. Operating Income per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$1.26
FY2025
5-year range
-$2.58 / -$1.26
FY2021-FY2025
Trend
+49.3%
vs FY2024
Sector context
#93 of 199
Health Care
What the data says
At $-1.26, Day One Biopharmaceuticals, Inc.'s operating income per share ranks #93 of 199 in the Health Care sector. Improved from $-2.58 to $-1.26 over the past 2 years.
Based on SEC 10-K filings.
-1.26 in FY2025.
Improved from $-2.58 to $-1.26 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#93 of 199 in Health CareTop 47% of 199This company -$1.26 Sector average -$3.34
▼
+62.1% above sector average
Key checks
Key Insights
- In FY2025, operating income per share increased 49.3% year-over-year.
- Ranks #93 out of 199 companies in the Health Care sector.
- Lowest operating income per share in the period was in FY2023.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.26 | +49.3% |
| FY2024 | -$2.49 | +3.6% |
| FY2023 | -$2.58 | -15.1% |
| FY2022 | -$2.24 | -14.0% |
| FY2021 | -$1.97 | +21.0% |
| FY2020 | -$2.49 | +0.9% |
| FY2019 | -$2.52 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026